Increased exhaled carbon monoxide concentration during living donor liver transplantation

International Journal of Molecular Medicine

Volumn 21, Issue 1, 2008, Pages 75-81

  Matsusaki, Takashi ^a   Morimatsu, Hiroshi ^a   Takahashi, Toru ^a   Matsumi, Masaki ^a   Sato, Kenji ^a   Kaku, Ryuji ^a   Sato, Tetsufumi ^a   Yagi, Takahito ^a   Tanaka, Noriaki ^a   Morita, Kiyoshi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Bilirubin IX ; Carboxyhemoglobin; Endothelial cell injury; Heme oxygenase; Ischemia reperfusion

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; EXHALED CARBON MONOXIDE; INTERCELLULAR ADHESION MOLECULE 1; THROMBOMODULIN; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANESTHESIA INDUCTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL DAMAGE; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPERFUSION;

EID: 38949197407     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.21.1.75     Document Type: Article

References (38)

1. Said A, Einstein M and Lucey MR: Liver transplantation: an update 2007. Curr Opin Gastroenterol 23: 292-298, 2007.
2. Brown RS Jr, Russo MW, Lai M, Shiffman ML, Richardson MC, Everhart JE and Hoofnagle JH: A survey of liver transplantation from living adult donors in the United States. N Engl J Med 348: 818-825, 2003.
3. Farmer DG, Amersia F, Kupiec-Weglinski JW and Busuttil RW: Current status of ischemia and reperfusion injury in the liver. Transplant Rev 14: 106-126, 2000.
4. Kupiec-Weglinski JW and Busuttil RW: Ischemia and reperfusion injury in liver transplantation. Transplant Proc 37: 1653-1656, 2005.
5. Marilena G: New physiological importance of two classic residual products: carbon monoxide and bilirubin. Biochem Mol Med 61: 136-142,1997.
6. Sassa S: Inhibition of carbon monoxide production by tinprotoporphyrin. J Pediatr Gastroenterol Nutr 6: 167-171, 1987.
7. Takahashi T, Morita K, Akagi R and Sassa S: Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries. Curr Med Chem 11: 1545-1561, 2004,
8. Takahashi T, Morita K, Akagi R and Sassa S: Defense against oxidative tissue injury: the essential role played by heme oxygenase-1. Curr Enzyme Inhib 2: 105-124, 2006.
9. Takahashi T, Shimizu H, Akagi R, Morita K and Sassa S: Heme oxygenase-1: a new drug target in oxidative tissue injuries in critically ill conditions. Drug Dev Res 67: 130-153, 2006.
10. Takahashi T, Shimizu H, Morimatsu H, Inoue K, Akagi R, Morita K and Sassa S: Herne oxygenase-1: a fundamental guardian against oxidative tissue injuries in acute inflammation. Mini Rev Med Chem 7: 745-753, 2007.
11. Kawakami T, Takahashi T, Shimizu H, Nakahira K, Takeuchi M, Katayama H, Yokoyama M, Morita K, Akagi R and Sassa S: Highly liver-specific heme oxygenase-1 induction by interleukin-11 prevents carbon tetrachloride-induced hepatotoxicity. Int J Mol Med 18: 537-546, 2006.
12. Tomita M, Okuyama T, Katsuyama H, Hidaka K, Otsuki T and Ishikawa T: Gene expression in rat lungs during early response to paraquat-induced oxidative stress. Int J Mol Med 17: 37-44, 2006.
13. Shibahara S: Regulation of heme oxygenase gene expression. Semin Hematol 25: 370-376, 1988.
14. Coburn RF, Forster RE and Kane PB: Considerations of the physiological variables that determine the blood carboxyhemoglobin concentration in man. J Clin Invest 44: 1899-1910, 1965.
15. Morimatsu H, Takahashi T, Maeshima K, Inoue K, Kawakami T, Shimizu H, Takeuchi M, Yokoyama M, Katayama H and Morita K: Increased heme catabolism in critically ill patients: correlation among exhaled carbon monoxide, arterial carboxy-hemoglobin, and serum bilirubin IXalpha concentrations. Am J Physiol Lung Cell Mol Physiol 290: L114-L119, 2006.
16. Boffa MC and Karmochkine M: Thrombomodulin: an overview and potential implications in vascular disorders. Lupus 7 (suppl 2): 120-125, 1998.
17. Gearing AJ and Newman W: Circulating adhesion molecules in disease. Immunol Today 14: 506-512, 1993.
18. Siemianowicz K, Francuz T, Gminski J, Telega A and Syzdol M: Endothelium dysfunction markers in patients with diabetic retinopathy. Int J Mol Med 15: 45 9-462, 2005.
19. Aggarwal S, Kang Y, Freeman J, DeWolf AM and Begliomini B: Is there a post-reperfusion syndrome? Transplant Proc 21: 3497-3499, 1989.
20. Zegdi R, Caid R, Van De Louw A, Perrin D, Burdin M, Boiteau R and Tenaillon A: Exhaled carbon monoxide in mechanically ventilated critically ill patients: influence of inspired oxygen fraction. Intensive Care Med 26: 1228-1231, 2000.
21. Tanaka K, Kobayashi Y and Kiuchi T: Current status of living donor liver transplantation in adults. Curr Opin Organ Transplant 5: 74-79, 2000.
22. Matsuda H, Yagi T, Sadamori H, Matsukawa H, Shinoura S, Murata H, Umeda Y and Tanaka N: Complications of arterial reconstruction in living donor liver transplantation: a single-center experience. Surg Today 36: 245-251, 2006.
23. Osteryoung J: Electrochemical methods of analysis. Methods Enzymol 158: 243-267, 1988.
24. Westphal M, Eletr D, Bone HG, Ertmer C, Weber TP, Aken HV and Booke M: Arteriovenous carboxyhemoglobin difference in critical illness: fiction or fact? Biochern Biophys Res Commun 299: 479-482, 2002.
25. Weber TP, Grosse Hartlage MA, Meyer J, Van Aken H, Uhlig S and Rolf N: Arteriovenous carboxyhemoglobin gradient is a technical artifact that is eliminated by special calibration (SAT 100). Biochem Biophys Res Commun 278: 447-448, 2000.
26. Horvath I, Donnelly LE, Kiss A, Paredi P, Kharitonov SA and Barnes PJ: Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress. Thorax 53: 668-672, 1998.
27. Montuschi P, Kharitonov SA and Barnes PJ: Exhaled carbon monoxide and nitric oxide in COPD. Chest 120: 496-501, 2001.
28. Paredi P, Shah PL, Montuschi P, Sullivan P, Hodson ME, Kharitonov SA and Barnes PJ: Increased carbon monoxide in exhaled air of patients with cystic fibrosis. Thorax 54: 917-920, 1999.
29. Scharte M, Bone HG, Van Aken H and Meyer J: Increased carbon monoxide in exhaled air of critically ill patients. Biochern Biophys Res Commun 267: 423-426, 2000.
30. Scharte M, von Ostrowski TA, Daudel F, Freise H, Van Aken H and Bone HG: Endogenous carbon monoxide production correlates weakly with severity of acute illness. Eur J Anaesthesiol 23: 117-122, 2006.
31. Zegdi R, Perrin D, Burdin M, Boiteau R and Tenaillon A: Increased endogenous carbon monoxide production in severe sepsis. Intensive Care Med 28: 793-796, 2002.
32. Schober P, Kalmanowicz M and Loer SA: Effects of inspiratory oxygen concentration on endtidal carbon monoxide concentration. J Clin Monit Comput 20: 89-94, 2006.
33. Ferrero ME, Orsi R and Bernelli-Zazzera A: Effects of ischemia on drug-metabolizing microsomal enzymes in rat liver. Exp Mol Pathol 28: 256-266, 1978.
34. Sassa S: Why heme needs to be degraded to iron, biliverdin IXalpha, and carbon monoxide? Antioxid Redox Signal 6: 819-824,2004.
35. Sassa S: Biological implications of heme metabolism. J Clin Biochern Nutr 38: 138-155, 2006.
36. Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW and Balla G: Pro-oxidant and cytotoxic effects of circulating heme. Blood 100: 879-887, 2002.
37. Wagener FA, da Silva JL, Farley T, de Witte T, Kappas A and Abraham NG: Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J Pharmacol Exp Ther 291: 416-423, 1999.
38. Wagener FA, Eggert A, Boerman OC, Oyen WJ, Verhofstad A, Abraham NG, Adema G, van Kooyk Y, de Witte T and Figdor CG: Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 98: 1802-1811, 2001.